Clinical Trials
Page 6 • 12 itemsAccess global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
GRAIL's Galleri Cancer Detection Test Shows Major Results in 174,000-Patient Studies at ASCO 2026
GRAIL presents breakthrough NHS-Galleri and PATHFINDER 2 trial data for multi-cancer early detection test at ASCO 2026, covering 174,000+ participants.
Eupraxia Pharmaceuticals Reports Positive 36-Week Data from Highest Dose Cohort in Eosinophilic Esophagitis RESOLVE Trial
Eupraxia's highest dose cohort shows robust tissue health and symptom improvements at 36 weeks in Phase 1b/2a eosinophilic esophagitis trial.
Karyopharm Phase 3 SENTRY Trial Results Selected for ASCO 2026 Late-Breaking Presentation in Myelofibrosis
Karyopharm's Phase 3 SENTRY trial in myelofibrosis earns prestigious late-breaking oral presentation slot at ASCO 2026, signaling potential breakthrough results.
Allogene Therapeutics Expands Cemacabtagene Ansegedleucel Phase 2 ALPHA3 Trial to South Korea and Australia
Allogene Therapeutics receives regulatory clearance to expand pivotal Phase 2 ALPHA3 trial of cemacabtagene ansegedleucel to South Korea and Australia markets.
Clinical Trial Transparency Europe: Impact of New Results Reporting Rules
This article delves into the implications of new clinical trial results reporting rules in Europe, focusing on drug XYZ's effectiveness for condition ABC.
EU vs US Clinical Trial Protocols: Key Differences in Design & Timelines
This article delves into the critical differences in clinical trial design and timelines between the EU and US, focusing on DrugX for ConditionY.
BriaCell Bria-OTS+ Shows Preserved Quality of Life in Phase 3 Metastatic Breast Cancer Trial at AACR 2026
BriaCell's Bria-OTS+ maintains quality of life in heavily pretreated metastatic breast cancer patients, with new biomarker data presented at AACR 2026.
Implantica RefluxStop Device Shows Excellent Long-Term Safety in Landmark 602-Patient European Study
Implantica's RefluxStop acid reflux device demonstrates excellent long-term safety in largest real-world study of 602 patients across 22 European centers.
AskBio's Ametefgene Parvec Enters Phase II Trial for Parkinson's Disease Gene Therapy
AskBio advances Ametefgene parvec (AB-1005) to Phase II trials for Parkinson's disease using commercial-scale manufacturing at Viralgen facility.
European Academic Clinical Trials: Funding and Success Rates Analysis 2024-2026
This analysis delves into the funding landscape and success rates of European academic clinical trials, focusing on drug development for chronic diseases between 2024 and 2026.
EU Clinical Trial Regulation: Streamlining Cross-Border Multi-State Studies
The EU Clinical Trial Regulation simplifies the process for conducting cross-border multi-state studies, improving the efficiency of drug XYZ for treating ABC.
EMA Guidelines Patient-Reported Outcomes: What You Need to Know
Explore the latest EMA guidelines on patient-reported outcomes for drug XYZ, crucial for improving treatment strategies in condition ABC.